Circumferential and Focal Ablation of Barrett's Esophagus Containing Dysplasia

[1]  Kenneth J. Chang,et al.  Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. , 2008, Gastrointestinal endoscopy.

[2]  D. Fleischer,et al.  A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). , 2008, Endoscopy.

[3]  N. Shaheen,et al.  Our new president--Robert S. Sandler, MD, MPH. , 2008, Gastroenterology.

[4]  Kenneth J. Chang,et al.  213 A Randomized, Multicenter, Sham-Controlled Trial of Radiofrequency Ablation (RFA) for Subjects with Barrett's Esophagus (Be) Containing Dysplasia: Interim Results of the Aim Dysplasia Trial , 2008 .

[5]  P. Fockens,et al.  Effective treatment of early Barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system , 2008, Endoscopy.

[6]  C. D. Smith,et al.  Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system , 2007, Surgical Endoscopy.

[7]  Bergein F Overholt,et al.  Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. , 2005, Gastrointestinal endoscopy.

[8]  P. Shekelle,et al.  Dysplasia and Risk of Further Neoplastic Progression in a Regional Veterans Administration Barrett's Cohort , 2005, The American Journal of Gastroenterology.

[9]  S. Spechler,et al.  Dysplasia in Barrett's Esophagus: Limitations of Current Management Strategies , 2005, The American Journal of Gastroenterology.

[10]  N. Shaheen,et al.  Effect of a New Diagnosis of Barrett's Esophagus on Insurance Status , 2005, The American Journal of Gastroenterology.

[11]  A. Ippoliti,et al.  Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. , 2005, Gastrointestinal endoscopy.

[12]  K. Batts,et al.  Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. , 2004, Gastrointestinal endoscopy.

[13]  K. Griffith,et al.  Dysplasia in Barrett esophagus , 2004 .

[14]  R. Cestari,et al.  Long-term endoscopic surveillance of patients with Barrett's esophagus. incidence of dysplasia and adenocarcinoma: a prospective study , 2003, American Journal of Gastroenterology.

[15]  D. Faigel,et al.  Risk Factors for Dysplasia in Patients with Barrett's Esophagus (BE): Results from a Multicenter Consortium , 2003, Digestive Diseases and Sciences.

[16]  T. Smyrk,et al.  Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia , 2002, American Journal of Gastroenterology.

[17]  S. Spechler,et al.  Clinical practice. Barrett's Esophagus. , 2002, The New England journal of medicine.

[18]  P. Pronovost,et al.  Hospital volume is related to clinical and economic outcomes of esophageal resection in Maryland. , 2001, The Annals of thoracic surgery.

[19]  C. Gutschow,et al.  Demographic variations in the rising incidence of esophageal adenocarcinoma in white males , 2001, Cancer.

[20]  A. Sonnenberg,et al.  Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. , 2001, Gastroenterology.

[21]  Prateek Sharma,et al.  p53 protein overexpression in low grade dysplasia (LGD) in barrett's esophagus: Immunohistochemical marker predictive of progression , 2001, American Journal of Gastroenterology.

[22]  E. Montgomery,et al.  Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. , 2001, Human pathology.

[23]  J K Greenson,et al.  Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.

[24]  J. Goldblum,et al.  The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression , 2000, American Journal of Gastroenterology.

[25]  J. Goldblum,et al.  Original contributionThe diagnosis of low-grade dysplasia in Barrett’s esophagus and its implications for disease progression , 2000 .

[26]  R. Playford,et al.  Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study , 2000, BMJ : British Medical Journal.

[27]  Gary Longton,et al.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets , 2000, American Journal of Gastroenterology.

[28]  Patricia L. Blount,et al.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. , 2000 .

[29]  A. Lindgren,et al.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.

[30]  W. Richardson,et al.  Esophageal resection for cancer. , 1998, The Surgical clinics of North America.

[31]  G. Tytgat,et al.  Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma , 1998, Gut.

[32]  Kenneth K Wang,et al.  Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.

[33]  V. Sharma,et al.  Changing trends in esophageal cancer: a 15-year experience in a single center , 1998, American Journal of Gastroenterology.

[34]  J. Miller,et al.  Esophagectomy for cancer. , 1997, The Surgical clinics of North America.

[35]  M. Helfand,et al.  Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. , 1997, The American journal of gastroenterology.

[36]  J. Peters,et al.  Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. , 1994, The Journal of thoracic and cardiovascular surgery.

[37]  F. Ellis,et al.  Endoscopic surveillance of Barrett's esophagus. Does it help? , 1993, The Journal of thoracic and cardiovascular surgery.

[38]  J. Fraumeni,et al.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.

[39]  G Van Belle,et al.  Observer variation in the diagnosis of dysplasia in Barrett's esophagus. , 1988, Human pathology.

[40]  T. Hastie,et al.  Does cancer risk affect health-related quality of life in patients with Barrett's esophagus? , 2007, Gastrointestinal endoscopy.

[41]  C. D. Smith,et al.  Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device , 2005, Surgical Endoscopy And Other Interventional Techniques.

[42]  P. Dítě,et al.  [Barrett's esophagus]. , 2000, Bratislavske lekarske listy.

[43]  Dawn Provenzale,et al.  Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk , 1999, American Journal of Gastroenterology.

[44]  R. Sandler,et al.  The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. , 1997, The American journal of gastroenterology.